Back to Trades
Total Value
$536.6K
Net $203.8K sold
Filing Date
Jul 25, 2025
2 transactions
Sales
$203.8K
2 transactions
Trade Summary
On Jul 23, 2025 through Jul 24, 2025, AULT MILTON C III, Insider, sold $536.6K of Alzamend Neuro, Inc. (ALZN) across 2 transactions. The filing covers Common Stock and reflects net selling of $203.8K. Reported prices ranged from $2.32 to $2.95. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Alzamend Neuro, Inc.
- Ticker Symbol
- ALZN
- CIK
- 0001677077
Insider Information
- Role
- Insider
- Location
- LAS VEGAS, NV
Filing Details
- Filing Date
- Jul 25, 2025
- Transaction Date
- Jul 23, 2025
- Accession Number
- 0001214659-25-010933
- Form Type
- 4
- Net Trading Amount
- -$203.8K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 23, 2025 | Common Stock | 143,429 | $2.32 | C | $332.8K |
| Jul 23, 2025 | Common Stock | 59,516 | $2.95 | Sale | $175.6K |
| Jul 24, 2025 | Common Stock | 9,621 | $2.93 | Sale | $28.2K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jul 23, 2025 | ALZN derivative | 332.755 | — | C | — |
Want live alerts when AULT MILTON C III trades again?
Download Insider Trades to track ALZN, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents shares of common stock received upon conversion of Series B convertible preferred stock ("Series B Preferred").
- (F2)Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Hyperscale Data, Inc. ("HSD"). Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
- (F3)Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
- (F4)Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.
- (F5)The Conversion Price of the Series B Preferred is subject to adjustment as set forth in that certain of Designation of Preferences, Rights and Limitations of the Series B Convertible Voting Preferred Stock.
- (F6)The shares of Series B Preferred have no expiration date.
- (F7)Mr. Ault, the Executive Chairman of HSD, is deemed to have voting and investment power with respect to the securities held of record by HSD.